Pretty obvious with the deal Amgen cut ADXS last summer that they just to be included in this most excellent adventure. ADXS gets ongoing money from that deal and has HOT all to themselves.
"Dead-Bottom" Fair Valuation: ~1.2B or ~$30 per share Fair Valuation: ~1.6B-~2.2B or ~$40-$55 per share Valuation+ (on the high side): closer to ~2.5B or ~$75 per share
No way this thing should be below a billion in market cap. No way.